Alipay's Gold Selection List Gulen Fund was "delisted"

　　Net worth has fallen by nearly 34% in the past year, and investors are still enthusiastic about adding

　　positions.

　　Recently, Christian Democrats discovered that the various dimension rankings of the golden selection list on Alipay have hidden Ge Lan's CEIBS medical care.

Previously, the Alipay Fund's weekly sales list showed that Ge Lan's "China-Europe Medical and Health" ranked first, with a decline of more than 30% in the past year, and many Christians made up the more they fell.

The Alipay list shows that more than 300,000 people have made purchases in the past week.

The news that Gulen's fund was "delisted" from Alipay's gold election week sales list caused heated discussions.

　　Ant Fortune replied on February 14 that the "Weekly Sales Ranking" in the Ant Fortune Gold Selection List is based on the objective data of investors' purchases with a weekly dimension. Recently, with market fluctuations, investors have begun to allocate more stable Fixed Income and Fixed Income+ Products.

Ant Fortune further stated that the Golden Selection List is committed to selecting funds with relatively excellent long-term returns and excess returns on the basis of balanced allocation and industry and style tracks, but the short-term returns still depend to a considerable extent on market fluctuations.

We encourage investors to hold for a long time, and we also suggest that investors should not bet on the track alone and pay more attention to balanced allocation funds with patience.

　　Although the net value of the fund has fallen by nearly 34% in the past year, investors' enthusiasm for adding positions has not diminished.

In the fourth quarter, Ge Lan was promoted to the 100 billion-level fund manager, with a management scale of 110.339 billion yuan, an increase of 13.338 billion yuan over the third quarter.

　　With the continuous correction of the pharmaceutical sector, pharmaceutical-themed funds have generally retreated severely this year.

The data shows that as of February 11, there were 229 pharmaceutical-themed funds in the whole market (different shares are calculated separately), with an average decline of 19.31% since the beginning of this year, including 107 pharmaceutical funds such as Fuguo Precision Medicine, Qianhai Kaiyuan Medical and Health, and China-Europe Medical Innovation. It's down more than 20% this year.

　　Text / reporter Zhu Kaiyun